Funder: National Institutes of Health

Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | June 5, 2026 (New) | July 5, 2026 (Renewal/Resubmission/Revision)

Funding Amounts: No budget limit; project period up to 5 years; budgets must reflect actual needs.

Summary: Supports research to elucidate mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease and related dementias, aiming to identify novel therapeutic targets and interventions.

Key Information: Clinical trial optional; foreign organizations eligible; updated March 2025—review full FOA for changes.